LDN-209929 dihydrochloride

Overview

LDN-209929 dihydrochloride is a potent and selective haspin kinase inhibitor ( IC 50 =55 nM) with180-fold selectivity verses DYRK2 ( IC 50 =9.9 μM). LDN-209929 is a optimized analogue of LDN-192960 ( HY-13455 ).

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Obesity | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Haspin Kinase | Products > Signaling Pathways > DYRK

Product Information

• Catalog No.: HY-110320
• CAS No.: 1784281-97-5
• Molecular Formula: C17H19Cl3N2OS
• Molecular Weight: 405.77
• Purity: 98.33%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (6.16 mM); Clear solution
• Availability: In-stock

Source

Original product source